FIELD: pharmaceutical chemistry. SUBSTANCE: composition contains, wt %: active ingredient selegilin, i.e. (-)-N-(dimethyl-N-(2-propylphenylethylamine), and/or its salts, 0.1-40; lipids, preferably phospholipids, 2-40; cholesterol, 0-10; ethanol, 0-20; ethylene glycol, 0-25; antioxidant, 0-3; preservative, 0-3; viscosity- modifying agent, 0-2; cyclodextrine or its derivative, 0-50; water, 30-90. Composition can be administered for treatment of Alzheimer disease, Parkinson disease, depression, paralysis, locomotor disorders, and myelitis. EFFECT: enhanced therapeutic efficiency. 17 cl, 9 dwg, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION AND A METHOD OF ITS PREPARING, METHOD OF TREATMENT OF DISORDERS CAUSED BY NEURODEGENERATIVE PROCESSES | 1992 |
|
RU2125448C1 |
TLATRATE OF 7-ISOPROPOXYISOFLAVONE AND CYCLODEXTRINE POLYMER SHOWING ACTIVITY AGAINST OSTEOPOROSIS AND OSTEOMALACIA | 1987 |
|
RU2022970C1 |
TRANSDERMAL ANHYDROUS COMPOSITION, METHOD OF ITS PREPARING AND APPLICATION | 1992 |
|
RU2088617C1 |
METHOD OF SYNTHESIS OF PROPARGYL AMMONIUM CHLORIDE DERIVATIVES | 1994 |
|
RU2130450C1 |
ANTIMICROBIAL COMPOSITION | 1991 |
|
RU2030913C1 |
FUNGICIDE SYNERGISTIC COMPOSITION | 1990 |
|
RU2091025C1 |
LYOTROPIC LIQUID CRYSTALLINE COMPOSITION | 1990 |
|
RU2045564C1 |
FUNGICIDE SYNERGISTIC COMPOSITION | 1990 |
|
RU2012205C1 |
DERIVATIVES OF 3,6-SUBSTITUTED-1,2,4,5-TETRAZINE, METHODS OF THEIR SYNTHESIS, LARVICIDE AND OVICIDE-ACTIVE COMPOSITION, METHOD OF ITS PREPARING AND METHOD OF DECREASE OF AMOUNT OF MITE LARVAE AND EGGS | 1994 |
|
RU2142949C1 |
PROCESS FOR PREPARING PHENYLKYLAMINES OR SALTS OF THESE COMPOUNDS | 1990 |
|
RU2015960C1 |
Authors
Dates
2000-11-20—Published
1995-10-20—Filed